MedGen Inc (MDIN)

[Jammin1]

Of course, these are deferred revenues you're talking about. Still, at 13 mill for 2 quarters, that projects to over 3 and a half cents per share in revenue over 4 quarters.

Even if you just look at non-deferred, last reported quarter's $153k in real sales projects to .00087 per share over 4 quarters, and with this past (still unreported) quarter up about 400% from that, we should be up to at least .0040 per share in annualized non-deferred sales.

So, in my opinion, this is a very safe level at which to buy.